Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Dec 02, 2020 7:20pm

162 Views

Post# 32023272

todays trades

ouse Positions for C:VXL from 20201202 to 20201202

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
85 Scotia	74,000	6,290	0.085	15,050	1,278	0.085	58,950	-5,012
79 CIBC	48,000	4,280	0.089	3,585	304	0.085	44,415	-3,976
89 Raymond James	6,952	625	0.09	0			6,952	-625
88 Credential	6,000	510	0.085	0			6,000	-510
9 BMO Nesbitt	5,000	425	0.085	2,000	170	0.085	3,000	-255
80 National Bank	11,000	990	0.09	10,000	850	0.085	1,000	-140
68 Leede	575	48	0.083	0			575	-48
33 Canaccord	0			11,000	990	0.09	-11,000	990
2 RBC	1,000	85	0.085	20,202	1,718	0.085	-19,202	1,633
7 TD Sec	2,535	215	0.085	26,225	2,232	0.085	-23,690	2,017
1 Anonymous	14,000	1,190	0.085	81,000	7,115	0.088	-67,000	5,925
TOTAL	169,062	14,658	0.087	169,062	14,657	0.087	0	-1